677 related articles for article (PubMed ID: 9704717)
1. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher B; Bryant J; Wolmark N; Mamounas E; Brown A; Fisher ER; Wickerham DL; Begovic M; DeCillis A; Robidoux A; Margolese RG; Cruz AB; Hoehn JL; Lees AW; Dimitrov NV; Bear HD
J Clin Oncol; 1998 Aug; 16(8):2672-85. PubMed ID: 9704717
[TBL] [Abstract][Full Text] [Related]
2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher B; Bryant J; Wolmark N; Mamounas E; Brown A; Fisher ER; Wickerham DL; Begovic M; DeCillis A; Robidoux A; Margolese RG; Cruz AB; Hoehn JL; Lees AW; Dimitrov NV; Bear HD
J Clin Oncol; 2023 Apr; 41(10):1795-1808. PubMed ID: 36989610
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
4. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
Fisher B; Brown A; Mamounas E; Wieand S; Robidoux A; Margolese RG; Cruz AB; Fisher ER; Wickerham DL; Wolmark N; DeCillis A; Hoehn JL; Lees AW; Dimitrov NV
J Clin Oncol; 1997 Jul; 15(7):2483-93. PubMed ID: 9215816
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.
Wolmark N; Wang J; Mamounas E; Bryant J; Fisher B
J Natl Cancer Inst Monogr; 2001; (30):96-102. PubMed ID: 11773300
[TBL] [Abstract][Full Text] [Related]
6. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N
J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Rastogi P; Anderson SJ; Bear HD; Geyer CE; Kahlenberg MS; Robidoux A; Margolese RG; Hoehn JL; Vogel VG; Dakhil SR; Tamkus D; King KM; Pajon ER; Wright MJ; Robert J; Paik S; Mamounas EP; Wolmark N
J Clin Oncol; 2008 Feb; 26(5):778-85. PubMed ID: 18258986
[TBL] [Abstract][Full Text] [Related]
8. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Bear HD; Anderson S; Brown A; Smith R; Mamounas EP; Fisher B; Margolese R; Theoret H; Soran A; Wickerham DL; Wolmark N;
J Clin Oncol; 2003 Nov; 21(22):4165-74. PubMed ID: 14559892
[TBL] [Abstract][Full Text] [Related]
9. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG
J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228
[TBL] [Abstract][Full Text] [Related]
10. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Bear HD; Anderson S; Smith RE; Geyer CE; Mamounas EP; Fisher B; Brown AM; Robidoux A; Margolese R; Kahlenberg MS; Paik S; Soran A; Wickerham DL; Wolmark N
J Clin Oncol; 2006 May; 24(13):2019-27. PubMed ID: 16606972
[TBL] [Abstract][Full Text] [Related]
11. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
Fisher B; Brown AM; Dimitrov NV; Poisson R; Redmond C; Margolese RG; Bowman D; Wolmark N; Wickerham DL; Kardinal CG
J Clin Oncol; 1990 Sep; 8(9):1483-96. PubMed ID: 2202791
[TBL] [Abstract][Full Text] [Related]
12. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
Fisher B; Jeong JH; Anderson S; Wolmark N
J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
[TBL] [Abstract][Full Text] [Related]
13. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
Fisher B; Redmond C; Legault-Poisson S; Dimitrov NV; Brown AM; Wickerham DL; Wolmark N; Margolese RG; Bowman D; Glass AG
J Clin Oncol; 1990 Jun; 8(6):1005-18. PubMed ID: 2189950
[TBL] [Abstract][Full Text] [Related]
14. Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes.
Fumoleau P; Chauvin F; Namer M; Bugat R; Tubiana-Hulin M; Guastalla JP; Delozier T; Kerbrat P; Devaux Y; Bonneterre J; Filleul A; Clavel M
J Clin Oncol; 2001 Feb; 19(3):612-20. PubMed ID: 11157010
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
Jones SE; Savin MA; Holmes FA; O'Shaughnessy JA; Blum JL; Vukelja S; McIntyre KJ; Pippen JE; Bordelon JH; Kirby R; Sandbach J; Hyman WJ; Khandelwal P; Negron AG; Richards DA; Anthony SP; Mennel RG; Boehm KA; Meyer WG; Asmar L
J Clin Oncol; 2006 Dec; 24(34):5381-7. PubMed ID: 17135639
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
van der Hage JA; van de Velde CJ; Julien JP; Tubiana-Hulin M; Vandervelden C; Duchateau L
J Clin Oncol; 2001 Nov; 19(22):4224-37. PubMed ID: 11709566
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.
Mamounas EP; Bryant J; Lembersky B; Fehrenbacher L; Sedlacek SM; Fisher B; Wickerham DL; Yothers G; Soran A; Wolmark N
J Clin Oncol; 2005 Jun; 23(16):3686-96. PubMed ID: 15897552
[TBL] [Abstract][Full Text] [Related]
18. NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel.
Mamounas EP
Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):37-40. PubMed ID: 9213327
[TBL] [Abstract][Full Text] [Related]
19. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Gianni L; Baselga J; Eiermann W; Porta VG; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Cussac AL; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez JJ; Mansutti M; Valagussa P; Bonadonna G
J Clin Oncol; 2009 May; 27(15):2474-81. PubMed ID: 19332727
[TBL] [Abstract][Full Text] [Related]
20. Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25.
Fisher B; Anderson S; DeCillis A; Dimitrov N; Atkins JN; Fehrenbacher L; Henry PH; Romond EH; Lanier KS; Davila E; Kardinal CG; Laufman L; Pierce HI; Abramson N; Keller AM; Hamm JT; Wickerham DL; Begovic M; Tan-Chiu E; Tian W; Wolmark N
J Clin Oncol; 1999 Nov; 17(11):3374-88. PubMed ID: 10550131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
